Researcher
Jasmien Cornillie
- Disciplines:Laboratory medicine, Palliative care and end-of-life care, Regenerative medicine, Other basic sciences, Other health sciences, Nursing, Other paramedical sciences, Other translational sciences, Other medical and health sciences
Affiliations
- Laboratory of Experimental Oncology (Division)
Member
From1 Aug 2013 → 30 Nov 2017
Projects
1 - 1 of 1
- Targeting soft tissue sarcoma with smart molecules - exploring cytotoxic prodrugs and target-specific inhibitors in patient-derived xenograftsFrom1 Aug 2013 → 30 Nov 2017Funding: Nonprofit institution or equivalents
Publications
1 - 9 of 9
- In vivo antitumoral efficacy of PhAc-ALGP-doxorubicin, an enzyme-activated doxorubicin prodrug, in patient-derived soft tissue sarcoma xenograft models(2017)
Authors: Jasmien Cornillie, Agnieszka Wozniak, Peter Pokreisz, Andrea Casazza, Yemarshet Kelemework Gebreyohannes, Maria Debiec-Rychter, Raf Sciot, Daphne Hompes, Patrick Schöffski
Pages: 1566 - 1575 - Treatment options for anthracycline-resistant, advanced soft-tissue sarcoma: the role of eribulin(2017)
Authors: Patrick Schöffski, Tom van Cann, Jasmien Cornillie
Pages: 445 - 453 - Single-Center Experience with Intimal Sarcoma, an Ultra-Orphan, Commonly Fatal Mesenchymal Malignancy(2017)
Authors: Raf Sciot, Marion Delcroix, Maria Debiec-Rychter, Barbara Dewaele, Jasmien Cornillie, Tom van Cann, Bart Meyns, Patrick Schöffski
Pages: 353 - 359 - Cabozantinib is active against human gastrointestinal stromal tumor xenografts carrying different KIT mutations(2016)
Authors: Yemarshet Kelemework Gebreyohannes, Patrick Schöffski, Jasmien Cornillie, Maria Debiec-Rychter, Raf Sciot, Agnieszka Wozniak
Pages: 2845 - 2852 - Biology and management of clear cell sarcoma: state of the art and future perspectives(2016)
Authors: Jasmien Cornillie, Tom van Cann, Agnieszka Wozniak, Daphne Hompes, Patrick Schöffski
Pages: 839 - 845 - Efficacy of an innovative, enzyme-activated doxorubicin prodrug in patient-derived dedifferentiated liposarcoma and synovial sarcoma xenograft models(2015)
Authors: Jasmien Cornillie, Agnieszka Wozniak, Lise Vreys, Haifu Li, Thomas Van Looy, Jasmien Wellens, Ulla Vanleeuw, Andre Trouet, Peter Pokreisz, Daphne Hompes, et al.
- Pazopanib, a Receptor Tyrosine Kinase Inhibitor, Suppresses Tumor Growth through Angiogenesis in Dedifferentiated Liposarcoma Xenograft Models(2014)
Authors: Haifu Li, Agnieszka Wozniak, Raf Sciot, Jasmien Cornillie, Thomas Van Looy, Marguerite Stas, Daphne Hompes, Maria Debiec-Rychter, Patrick Schöffski
Pages: 665 - 71 - Characterization and assessment of the sensitivity and resistance of a newly established human gastrointestinal stromal tumour xenograft model to treatment with tyrosine kinase inhibitors(2014)
Authors: Thomas Van Looy, Yemarshet Kelemework Gebreyohannes, Agnieszka Wozniak, Jasmien Cornillie, Haifu Li, Beppe Floris, Maria Debiec-Rychter, Raf Sciot, Patrick Schöffski
Pages: 10 - Soft tissue sarcoma: an update on systemic treatment options for patients with advanced disease(2014)
Authors: Patrick Schöffski, Jasmien Cornillie, Agnieszka Wozniak, Haifu Li, Daphne Hompes
Pages: 355 - 62